Cormark analyst Jesse Pytlak downgraded Curaleaf (CURLF) to Market Perform from Speculative Buy with a C$3.75 price target
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf price target lowered to C$6.50 from C$11 at Alliance Global Partners
- Curaleaf Holdings Reports Q3 2024 Results
- Curaleaf Holdings Reports Steady Growth Amid Challenges
- Rising High: RIV Capital provides update on revenue, synergy realization
- Kansas, Utah voters support marijuana legalization, Marijuana Moment says